TBL1X expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.019800E-01
Normal-vs-Stage2
1.313960E-01
Normal-vs-Stage3
2.147700E-02
Normal-vs-Stage4
2.906000E-01
Stage1-vs-Stage2
8.541900E-03
Stage1-vs-Stage3
5.179500E-02
Stage1-vs-Stage4
2.521600E-01
Stage2-vs-Stage3
1.657770E-01
Stage2-vs-Stage4
9.080600E-01
Stage3-vs-Stage4
2.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.368200E-01
Normal-vs-AfricanAmerican
5.218200E-01
Normal-vs-Asian
6.519800E-02
Caucasian-vs-AfricanAmerican
6.516400E-01
Caucasian-vs-Asian
2.378400E-01
AfricanAmerican-vs-Asian
9.548100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.565200E-01
Normal-vs-Female
3.505800E-01
Male-vs-Female
8.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.893800E-01
Normal-vs-Age(41-60Yrs)
6.163200E-01
Normal-vs-Age(61-80Yrs)
3.618200E-01
Normal-vs-Age(81-100Yrs)
5.959400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.773000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.688000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.446400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.310400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.430300E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.411800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.469500E-02
Normal-vs-Daily Drinker
6.946800E-01
Normal-vs-Weekly Drinker
1.014790E-01
Normal-vs-Occasional Drinker
8.639800E-01
Normal-vs-Social Drinker
6.748400E-01
Non Drinker-vs-Daily Drinker
5.076500E-02
Non Drinker-vs-Weekly Drinker
4.527800E-01
Non Drinker-vs-Occasional Drinker
2.452400E-02
Non Drinker-vs-Social Drinker
7.520300E-02
Daily Drinker-vs-Weekly Drinker
1.835990E-01
Daily Drinker-vs-Occasional Drinker
6.765800E-01
Daily Drinker-vs-Social Drinker
9.950200E-01
Weekly Drinker-vs-Occasional Drinker
9.024200E-02
Weekly Drinker-vs-Social Drinker
2.205400E-01
Occasional Drinker-vs-Social Drinker
6.974200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.825600E-01
Normal-vs-Grade 2
9.807600E-02
Normal-vs-Grade 3
9.296400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.218100E-02
Grade 1-vs-Grade 3
4.571800E-02
Grade 1-vs-Grade 4
2.825600E-01
Grade 2-vs-Grade 3
6.241800E-01
Grade 2-vs-Grade 4
9.807600E-02
Grade 3-vs-Grade 4
9.296400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.717240E-01
Normal-vs-NonDiabetic
5.143200E-01
Diabetic-vs-NonDiabetic
2.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.239000E-01
Normal-vs-NoPancreatitis
4.213600E-01
Pancreatitis-vs-NoPancreatitis
9.085400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.981800E-01
Normal-vs-N1
1.466590E-01
N0-vs-N1
1.892820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.022570E-01
Normal-vs-TP53-NonMutant
9.161400E-01
TP53-Mutant-vs-TP53-NonMutant
3.575100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
